Last reviewed · How we verify
HRG2010 Capsule, Sinemet®, Madopar® — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
HRG2010 Capsule, Sinemet®, Madopar® (HRG2010 Capsule, Sinemet®, Madopar®) — Jiangsu HengRui Medicine Co., Ltd..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| HRG2010 Capsule, Sinemet®, Madopar® TARGET | HRG2010 Capsule, Sinemet®, Madopar® | Jiangsu HengRui Medicine Co., Ltd. | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- HRG2010 Capsule, Sinemet®, Madopar® CI watch — RSS
- HRG2010 Capsule, Sinemet®, Madopar® CI watch — Atom
- HRG2010 Capsule, Sinemet®, Madopar® CI watch — JSON
- HRG2010 Capsule, Sinemet®, Madopar® alone — RSS
Cite this brief
Drug Landscape (2026). HRG2010 Capsule, Sinemet®, Madopar® — Competitive Intelligence Brief. https://druglandscape.com/ci/hrg2010-capsule-sinemet-madopar. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab